CVAC240719P5000
- 1.85
- 0.000.00%
CureVac Newsroom
CureVac: A Buy Rating Amidst Intellectual Property Litigation and Strong Valuation Metrics
Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Insmed (INSM) and Quest Diagnostics (DGX)
CureVac Analyst Ratings
CureVac's Strategic Realignment and Positive Financial Outlook Prompt Buy Rating
Buy Rating on CureVac: Positive Financial Outlook and Promising Vaccine Trials Fuel Optimism
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Revance Therapeutics (RVNC) and CureVac (CVAC)
Deutsche Numis Keeps Their Hold Rating on CureVac (CVAC)
CureVac Analyst Ratings
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and BioMarin Pharmaceutical (BMRN)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC)
CureVac Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), CureVac (CVAC) and Immunocore Holdings (IMCR)
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and Evolus (EOLS)
Kempen Upgrades CureVac to Buy From Neutral, Price Target Is $10
Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Marinus (MRNS) and Vertex Pharmaceuticals (VRTX)
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), CureVac (CVAC) and BioNTech SE (BNTX)
CureVac Buy Rating Affirmed Despite Patent Setback, Strong Appeal Prospects Anticipated
Deutsche Bank Sticks to Their Hold Rating for CureVac (CVAC)
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA)
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), CureVac (CVAC) and Roche Holding AG (OtherRHHVF)